Scholar Rock Holding Corp (SRRK)
45.56
+1.60
(+3.64%)
USD |
NASDAQ |
Dec 24, 16:00
Scholar Rock Cash from Investing (Quarterly): 35.31M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Cytokinetics Inc | -45.05M |
| Cassava Sciences Inc | -0.017M |
| Regeneron Pharmaceuticals Inc | -574.40M |
| Ocugen Inc | -0.507M |
| BridgeBio Pharma Inc | 38.23M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -52.46M |
| Cash from Financing (Quarterly) | 0.166M |
| Free Cash Flow | -188.86M |
| Free Cash Flow Per Share (Quarterly) | -0.5408 |
| Free Cash Flow Yield | -4.33% |